GPR42 Activators are a class of chemical agents designed to specifically interact with and enhance the activity of the GPR42 receptor. GPR42, a member of the G protein-coupled receptor (GPCR) family, is a receptor that is closely related to the GPR41, also known as free fatty acid receptor 3 (FFAR3). These receptors are known to be activated by short-chain fatty acids (SCFAs) that are primarily produced by the fermentation of dietary fibers in the gut by the resident microbiota. The activators of GPR42 could be molecules that mimic the effect of natural ligands or SCFAs, facilitating the receptor's activation and subsequent intracellular signaling cascades. The development of such activators requires a detailed understanding of the receptor's ligand-binding domain and the conformational changes necessary for activation. Researchers would need to delve into the receptor's three-dimensional structure and the interaction dynamics between GPR42 and its activators to design effective molecules.
The identification and optimization of GPR42 activators would typically involve an iterative process of structure-activity relationship (SAR) studies, where chemists synthesize a range of chemical compounds with variations in their structures to determine the features necessary for receptor activation. Initial hits could be found using high-throughput screening of chemical libraries to identify compounds that elicit a response from cells expressing GPR42. These initial activators would then be optimized for greater potency and selectivity through medicinal chemistry approaches. On the experimental front, various in vitro assays, such as those measuring second messenger levels (e.g., cAMP, Ca2+ flux), would be critical for assessing the ability of these compounds to activate GPR42. Furthermore, studying the interaction of these activators with GPR42 using biophysical methods like surface plasmon resonance (SPR) or nuclear magnetic resonance (NMR) spectroscopy could provide insights into the binding mechanism and kinetics. Through such detailed investigations, scientists would not only gain a deeper understanding of GPR42's activation but also generate a platform for the development of more sophisticated activators that can interact with the receptor with high precision.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
As an SCFA, butyric acid might interact with GPR42 analogously to GPR41, potentially influencing its expression. | ||||||
Acetic acid | 64-19-7 | sc-214462 sc-214462A | 500 ml 2.5 L | $63.00 $106.00 | 5 | |
Acetic acid is a short-chain fatty acid that may modulate GPCR expression, including that of GPR42, through metabolic signaling. | ||||||
Lithocholic acid | 434-13-9 | sc-215262 sc-215262A | 10 g 25 g | $100.00 $272.00 | 1 | |
A bile acid that might influence GPCR expression as part of the enterohepatic signaling network. | ||||||
Chenodeoxycholic acid, free acid | 474-25-9 | sc-278835 sc-278835A | 1 g 5 g | $28.00 $117.00 | ||
Another bile acid that could serve as a signaling molecule affecting GPCR expression, including GPR42. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A metabolite of vitamin A that acts as a ligand for nuclear receptors and may influence the expression of a range of GPCRs. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Vitamin D3 acts via nuclear receptors that can regulate gene expression, potentially affecting GPCRs like GPR42. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C, which is involved in numerous signaling pathways that can modulate GPCR expression. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
As a PPAR-gamma agonist, rosiglitazone may influence the expression of various genes, including GPCRs. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
As a hormone and neurotransmitter, epinephrine might regulate GPCR expression through adrenergic receptor-mediated pathways. | ||||||